The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit, J Neurol Sci, vol.264, pp.121-129, 2008. ,
Early predictors of mechanical ventilation in Guillain-Barr?? syndrome, Critical Care Medicine, vol.31, issue.1, pp.278-83, 2003. ,
DOI : 10.1097/00003246-200301000-00044
Epidemiological study of Guillain-Barre syndrome in south east England, Journal of Neurology, Neurosurgery & Psychiatry, vol.64, issue.1, pp.74-81, 1998. ,
DOI : 10.1136/jnnp.64.1.74
De l'épidémie actuellement régnante à Paris, Journal Hebdomadaire de Médecine. Paris, pp.331-339, 1828. ,
Note sur la paralysie ascendante aiguë. Gaz Hebd Med Chir, pp.472-88, 1859. ,
Histoire du syndrome de Guillain et Barré, Paris, vol.12, 1982. ,
Sur un syndrome de radiculonevrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineaux, 1916. ,
Diagnostic considerations in Guillain-Barré syndrome, Ann Neurol, vol.9, 1981. ,
Assessment of current diagnostic criteria for Guillain-Barr??? syndrome, Annals of Neurology, vol.10, issue.S1, pp.21-25, 1990. ,
DOI : 10.1002/ana.410270707
Guillain-Barré syndrome. The Lancet, pp.1653-66, 2005. ,
Ce malade est-il atteint d'un syndrome de Guillain-Barré ? Réanimation, pp.504-514, 2007. ,
Long term disability and social status change after Guillain???Barr?? syndrome, Journal of Neurology, vol.51, issue.2, pp.214-222, 2006. ,
DOI : 10.1212/WNL.59.2.282
Risk factors for treatment related clinical fluctuations in Guillain-Barré syndrome. Dutch Guillain-Barré study group Distinguishing acute-onset CIDP from Guillain- Barré syndrome with treatment related fluctuations Assessment of autonomic dysfunction in Guillain-Barré syndrome and its prognostic implications, 242?4. 14. Ruts L138?40. 15. Singh NK, pp.101-106, 1987. ,
A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value., Journal of Neurology, Neurosurgery & Psychiatry, vol.51, issue.5, pp.605-617, 1988. ,
DOI : 10.1136/jnnp.51.5.605
Identification of patients at risk of arrhythmia in the Guillain-Barré syndrome, Q J Med, vol.68, pp.735-744, 1988. ,
Autonomic involvement in Guillain-Barre syndrome: A review, Muscle & Nerve, vol.461, issue.10, pp.1145-55, 1994. ,
DOI : 10.1536/ihj.26.593
Pain in Guillain-Barré syndrome Swedish Epidemiological Study Group. Impairment in Guillain-Barré syndrome during the first 2 years after onset: a prospective study, Arch Neurol. J Neurol Sci, vol.41227, pp.131-139, 1984. ,
Pain in the Guillain-Barré syndrome: a clinical review Pain in Guillain- Barre syndrome: a long-term follow-up study Cutaneous innervation in Guillain-Barré syndrome: pathology and clinical correlations, 159?64. 23. Ruts L1439?47. 24. Pan C, pp.386-97, 1994. ,
Pharmacological treatment for pain in Guillain-Barré syndrome, Cochrane Database Syst Rev, vol.10, 2013. ,
Fatigue, pain and muscle weakness are frequent after Guillain-Barr?? syndrome and poliomyelitis, Journal of Neurology, vol.63, issue.3, pp.349-54, 2009. ,
DOI : 10.1212/01.WNL.0000148589.87107.9C
Bickerstaff???s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain???Barr?? syndrome, Brain, vol.126, issue.10, pp.2279-90, 2003. ,
DOI : 10.1002/ana.1012
Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. Cochrane Database Syst Rev, 2007. ,
High incidence of Guillain-Barre syndrome in children Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curaçao, Bangladesh. Emerg Infect Dis. Neurology, vol.1756, issue.30, pp.1467-72, 2001. ,
Epidemiologic features of Guillain-Barr?? syndrome in S??o Paulo, Brazil, Arquivos de Neuro-Psiquiatria, vol.64, issue.Suppl1, pp.33-40, 2004. ,
DOI : 10.1136/jnnp.64.1.74
Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis123?33. 33. McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review, Neuroepidemiology. Neuroepidemiology, vol.3632, pp.150-63, 2009. ,
Clinical features, pathogenesis, and treatment of Guillain-Barr?? syndrome, The Lancet Neurology, vol.7, issue.10, pp.939-50, 2008. ,
DOI : 10.1016/S1474-4422(08)70215-1
Electrophysiological classification of guillain-barr?? syndrome: Clinical associations and outcome, Annals of Neurology, vol.18, issue.Suppl, pp.780-788, 1998. ,
DOI : 10.1007/BF00792612
Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh, Neurology, vol.74, issue.7, pp.581-588, 2010. ,
DOI : 10.1212/WNL.0b013e3181cff735
Recovery patterns and long term prognosis for axonal Guillain-Barre syndrome, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.5, pp.719-741, 2005. ,
DOI : 10.1136/jnnp.2004.051136
URL : http://jnnp.bmj.com/content/jnnp/76/5/719.full.pdf
infection and anti-glycolipid antibodies, Brain, vol.118, issue.3, pp.597-605, 1995. ,
DOI : 10.1093/brain/118.3.597
Fc receptor like 3 in Chinese patients of Han nationality with Guillain???Barr?? syndrome, Journal of Neuroimmunology, vol.246, issue.1-2, pp.65-73, 2012. ,
DOI : 10.1016/j.jneuroim.2012.03.006
infections and anti-GM1 antibodies in guillain-barr?? syndrome, Annals of Neurology, vol.24, issue.suppl, pp.181-188, 1996. ,
DOI : 10.1016/0140-6736(90)91234-2
The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study, Neurology, vol.51, issue.4, pp.1110-1115, 1998. ,
DOI : 10.1212/WNL.51.4.1110
Guillain???Barr?? Syndrome, New England Journal of Medicine, vol.366, issue.24, pp.2294-304, 2012. ,
DOI : 10.1056/NEJMra1114525
Role of Infection Due to Campylobacter jejuni in the Initiation of Guillain-Barre Syndrome, Clinical Infectious Diseases, vol.17, issue.1, pp.104-112, 1993. ,
DOI : 10.1093/clinids/17.1.104
Epidemiological and molecular analyses of a non-seasonal outbreak of acute icteric hepatitis E in Bangladesh, Journal of Medical Virology, vol.341, issue.8, pp.1369-76, 2013. ,
DOI : 10.1016/0140-6736(93)90599-C
Guillain???Barr?? syndrome and encephalitis/encephalopathy associated with acute severe hepatitis E infection, Neurological Sciences, vol.42, issue.1, 2014. ,
DOI : 10.2169/internalmedicine.42.220
Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis, Nat Rev Neurol, vol.35, 2014. ,
Die Influenza und das Nervensystem Studie w??hrend der Epidemie in Schweden 1918???1919, Zeitschrift f??r die gesamte Neurologie und Psychiatrie, vol.54, issue.1, pp.166-224, 1918. ,
DOI : 10.1007/BF02866117
The Nervous Conditions Associated with Influenza, Can Med Assoc J, vol.9, pp.727-758, 1919. ,
Guillain-Barr?? syndrome after exposure to influenza virus, The Lancet Infectious Diseases, vol.10, issue.9, pp.643-51, 2010. ,
DOI : 10.1016/S1473-3099(10)70140-7
Investigation of the Temporal Association of Guillain-Barre Syndrome With Influenza Vaccine and Influenzalike Illness Using the United Kingdom General Practice Research Database, American Journal of Epidemiology, vol.166, issue.20, pp.382-390, 2009. ,
DOI : 10.1001/archinte.166.20.2217
Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence Clin Infect Dis Off Publ Infect Dis Soc Am Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system, J Clin Neuromuscul Dis, vol.5814, pp.66-71, 1990. ,
Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, Am J Epidemiol, vol.110, pp.1976-1977105, 1979. ,
Guillain-Barré syndrome and the 1978- 1979 influenza vaccine Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans, N Engl J Med. Am J Epidemiol, vol.304175, pp.1110-1119, 1981. ,
The risk of Guillain-Barr?? syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States., American Journal of Public Health, vol.87, issue.12, pp.2045-2053, 1997. ,
DOI : 10.2105/AJPH.87.12.2045
Vaccines and Guillain-Barre syndrome, BMJ, vol.312, issue.7044, pp.1475-1481, 1996. ,
DOI : 10.1136/bmj.312.7044.1475d
Guillain-Barr?? Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in Europe, PLoS ONE, vol.169, issue.1, 2014. ,
DOI : 10.1371/journal.pone.0082222.t005
Guillain-Barr?? Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009???2011, PLoS ONE, vol.30, issue.6, p.67185, 2009. ,
DOI : 10.1371/journal.pone.0067185.s004
Guillain???Barr?? Syndrome???A Classical Autoimmune Disease Triggered by Infection or Vaccination, 121?30. 64. Nakayama T, Onoda K. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from, pp.570-576, 1994. ,
DOI : 10.1001/archinte.166.20.2217
Intensive care of acute Guillain-Barré syndrome, Can J Neurol Sci J Can Sci Neurol, vol.21, pp.23-30, 1994. ,
Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain???Barr?? syndrome, Intensive Care Medicine, vol.32, issue.Suppl, 2006. ,
DOI : 10.1164/ajrccm.159.6.9808030
Outcome and its predictors in Guillain???Barr?? syndrome, Journal of Neurology, Neurosurgery & Psychiatry, vol.83, issue.7, pp.711-719, 2012. ,
DOI : 10.1136/jnnp-2011-301882
The recurrent Guillain-Barré syndrome: a long-term population-based study154?61. 69. Lawn ND, Wijdicks EF. Fatal Guillain-Barré syndrome Mortality in Guillain-Barré syndrome, Medical Research Council. Aids to the examination of the peripheral nervous system. Her Majesty's Stationery Office, pp.1650-1654, 1981. ,
Aids to the Investigation of Peripheral Nerve Injuries. Medical Research Council: Nerve Injuries Research Committee. His Majesty's Stationery Office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with Aids to the Examination of the Peripheral Nervous System. By Michael O'Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 Figures, Brain, vol.133, issue.10, pp.2838-2882, 2010. ,
DOI : 10.1093/brain/awq270
Intravenous immunoglobulin for Guillain-Barré syndrome, Cochrane Database Syst Rev, vol.7, 2012. ,
Plasma exchange for Guillain-Barré syndrome, Cochrane Database Syst Rev, vol.7, 2012. ,
Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale, Journal of the Peripheral Nervous System, vol.49, issue.4, pp.268-78, 2009. ,
DOI : 10.1212/WNL.53.8.1648
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies, Neurology, vol.76, issue.4, pp.337-382, 2011. ,
DOI : 10.1212/WNL.0b013e318208824b
196th ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8???10 February 2013, Naarden, The Netherlands, Neuromuscular Disorders, vol.23, issue.11, pp.924-957, 2013. ,
DOI : 10.1016/j.nmd.2013.06.006
The Italian Guillain-Barre Study Group. The prognosis and main prognostic indicators of Guillain-Barre syndrome: a multicentre prospective study of 297 patients, Brain, vol.121, issue.4, pp.767-776, 1998. ,
DOI : 10.1093/brain/121.4.767
Long-term prognosis for Guillain-Barr?? syndrome: Evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis, Journal of Clinical Apheresis, vol.119, issue.4, pp.175-80, 2003. ,
DOI : 10.1093/brain/119.6.2053
Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey A clinical prognostic scoring system for Guillain-Barré syndrome Early recognition of poor prognosis in Guillain-Barre syndrome, Neurology. Lancet Neurol. Neurology, vol.6676, issue.82, pp.968-75, 2003. ,
Preceding infections, immune factors, and outcome in Guillain-Barre syndrome, Neurology, vol.56, issue.6, pp.758-65, 2001. ,
DOI : 10.1212/WNL.56.6.758
Clinical and electrophysiological predictors of respiratory failure in Guillain-Barr?? syndrome: a prospective study, The Lancet Neurology, vol.5, issue.12, pp.1021-1029, 2006. ,
DOI : 10.1016/S1474-4422(06)70603-2
Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange, Neurology, vol.53, issue.3, pp.598-604, 1999. ,
DOI : 10.1212/WNL.53.3.598
Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation, Neurology, vol.54, issue.12, pp.2311-2316, 2000. ,
DOI : 10.1212/WNL.54.12.2311
Indicators of rapid clinical recovery in Guillain-Barré syndrome Motor conduction studies in Guillain-Barré syndrome: description and prognostic value, J Neurol Neurosurg Psychiatry. Ann Neurol, vol.7023, pp.354-363, 1988. ,
IGOS International GBS Outcome Study: prognosis tool, 2015. ,
The morbidity of Guillain-Barre syndrome admitted to the intensive care unit, Neurology, vol.60, issue.1, pp.17-21, 2003. ,
DOI : 10.1212/01.WNL.0000035640.84053.5B
Guillain-Barre syndrome: Incidence and mortality rates in US hospitals, Neurology, vol.70, issue.18, pp.1608-1621, 2008. ,
DOI : 10.1212/01.wnl.0000310983.38724.d4
THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS, Medicine, vol.48, issue.3, pp.173-215, 1969. ,
DOI : 10.1097/00005792-196905000-00001
Pathology of the Guillain-Barr??? syndrome, Annals of Neurology, vol.27, issue.S1, pp.6-19, 1981. ,
DOI : 10.1001/archneur.1969.00480150059008
Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China Pathology of the motor-sensory axonal Guillain-Barré syndrome, 333?42. 95, pp.17-28, 1993. ,
A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo, J Immunol Baltim Md, vol.133, 1950. ,
T lymphocyte activation antigens in Guillain-Barr?? syndrome and chronic idiopathic demyelinating polyradiculoneuropathy, Journal of Neuroimmunology, vol.24, issue.1-2, pp.33-42, 1989. ,
DOI : 10.1016/0165-5728(89)90095-7
Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy, Acta Neurologica Scandinavica, vol.76, issue.suppl 1, pp.401-408, 1988. ,
DOI : 10.1212/WNL.35.10.1420
T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barr?? syndrome, Journal of the Neurological Sciences, vol.153, issue.1, pp.54-60, 1997. ,
DOI : 10.1016/S0022-510X(97)00178-0
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.10, pp.1431-1440, 2005. ,
DOI : 10.1136/jnnp.2004.052282
Stimulation of peripheral blood lymphocytes with Campylobacter jejuni generates a gammadelta T cell response in patients with Guillain-Barre syndrome, Clinical and Experimental Immunology, vol.109, issue.1, pp.121-127, 1997. ,
DOI : 10.1046/j.1365-2249.1997.4221318.x
CD1 expression in human peripheral nerve of GBS patients, Biochemical Society Transactions, vol.25, issue.2, p.172, 1997. ,
DOI : 10.1042/bst025172s
Susceptibility to Guillain???Barr?? syndrome is associated to polymorphisms of CD1 genes, Journal of Neuroimmunology, vol.177, issue.1-2, pp.201-202193, 2007. ,
DOI : 10.1016/j.jneuroim.2006.05.018
Susceptibility to Guillain???Barr?? syndrome is not associated with CD1A and CD1E gene polymorphisms, Journal of Neuroimmunology, vol.205, issue.1-2, pp.110-112, 2008. ,
DOI : 10.1016/j.jneuroim.2008.08.013
Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome, Brain Research, vol.745, issue.1-2, pp.32-38, 1997. ,
DOI : 10.1016/S0006-8993(96)01123-7
Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system, Chemistry and Physics of Lipids, vol.42, issue.1-3, pp.235-283, 1986. ,
DOI : 10.1016/0009-3084(86)90055-1
Axonal Guillain-Barr?? syndrome: concepts and controversies, The Lancet Neurology, vol.12, issue.12, pp.1180-1188, 2013. ,
DOI : 10.1016/S1474-4422(13)70215-1
Acute motor axonal neuropathy: An antibody-mediated attack on axolemma, Annals of Neurology, vol.99, issue.4, pp.635-679, 1996. ,
DOI : 10.1212/WNL.43.4.809
Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy, Annals of Neurology, vol.263, issue.5, pp.625-660, 1996. ,
DOI : 10.1212/WNL.37.2.242
Peripheral neuropathies and anti-glycolipid antibodies, Brain, vol.125, issue.12, pp.2591-625, 2002. ,
DOI : 10.1093/brain/awf272
URL : https://academic.oup.com/brain/article-pdf/125/12/2591/1115267/awf272.pdf
Anti-ganglioside complex antibodies associated with severe disability in GBS, Journal of Neuroimmunology, vol.182, issue.1-2, pp.212-220, 2007. ,
DOI : 10.1016/j.jneuroim.2006.09.013
Anti-ganglioside antibody and neuropathy: review of our research, J Peripher Nerv Syst JPNS, vol.3, pp.3-18, 1998. ,
Rapidly progressive, predominantly motor Guillain-Barre syndrome with anti-GalNAc-GD1a antibodies, Neurology, vol.53, issue.9, pp.2122-2129, 1999. ,
DOI : 10.1212/WNL.53.9.2122
Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome, Annals of Neurology, vol.44, issue.6, pp.677-686, 1992. ,
DOI : 10.1212/WNL.40.12.1900
Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside., Journal of Neurology, Neurosurgery & Psychiatry, vol.56, issue.2, pp.204-210, 1993. ,
DOI : 10.1136/jnnp.56.2.204
GM1b is a new member of antigen for serum antibody in Guillain-Barre syndrome, Neurology, vol.47, issue.1, pp.237-279, 1996. ,
DOI : 10.1212/WNL.47.1.237
The immunobiology of Guillain-Barre syndromes, Journal of the Peripheral Nervous System, vol.53, issue.2, pp.94-112, 2005. ,
DOI : 10.1007/s281-001-8167-7
Frequent presence of anti-GQ1b antibody in Fisher's syndrome, Neurology, vol.43, issue.2, pp.414-421, 1993. ,
DOI : 10.1212/WNL.43.2.414
Antibody to Ga1NAc-GD1a and Ga1NAc-GM1b in Guillain???Barr?? syndrome subsequent to Campylobacter jejuni enteritis, Journal of Neuroimmunology, vol.71, issue.1-2, pp.155-61, 1996. ,
DOI : 10.1016/S0165-5728(96)00142-7
Clinical features and response to treatment in Guillain-Barr??? syndrome associated with antibodies to GM1b ganglioside, Annals of Neurology, vol.21, issue.3, pp.314-335, 2000. ,
DOI : 10.1212/WNL.53.9.2122
Axonal Guillain-Barr?? syndrome: carbohydrate mimicry and pathophysiology, Journal of the Peripheral Nervous System, vol.40, issue.4, pp.238-287, 2007. ,
DOI : 10.1073/pnas.0402391101
Gangliosides of the neuron, Trends in Neurosciences, vol.8, pp.169-74, 1985. ,
DOI : 10.1016/0166-2236(85)90064-5
Serum factor in Miller-Fisher variant of Guillain-Barr?? syndrome and neurotransmitter release, The Lancet, vol.343, issue.8895, pp.454-459, 1994. ,
DOI : 10.1016/S0140-6736(94)92694-8
Monoclonal antibodies raised against Guillain-Barr?? syndrome???associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations, Journal of Clinical Investigation, vol.104, issue.6, pp.697-708, 1999. ,
DOI : 10.1172/JCI6837
Miller Fisher anti-GQ1b antibodies: ?-Latrotoxin-like effects on motor end plates, Annals of Neurology, vol.80, issue.2, pp.189-99, 1999. ,
DOI : 10.1016/S0165-5728(97)00127-6
Detection and prevalence of ?-latrotoxin-like effects of serum from patients with Guillain-Barr??? syndrome, Muscle & Nerve, vol.43, issue.4, pp.549-58, 2002. ,
DOI : 10.1212/WNL.43.2.414
Ganglioside complexes as new target antigens in Guillain-Barr?? syndrome, Annals of Neurology, vol.2, issue.suppl, pp.567-71, 2004. ,
DOI : 10.1016/S0140-6736(78)92644-2
Antibodies to gangliosides and ganglioside complexes in Guillain???Barr?? syndrome and Fisher syndrome: Mini-review, Journal of Neuroimmunology, vol.223, issue.1-2, pp.5-12, 2010. ,
DOI : 10.1016/j.jneuroim.2010.02.001
Antiganglioside antibodies???Their pathophysiological effects on Guillain-Barr?? Syndrome and variants???, Japanese Journal of Clinical Immunology, vol.34, issue.1, pp.29-39, 2011. ,
DOI : 10.2177/jsci.34.29
Immune-mediated neuropathy and anti-glycolipid antibodies, Brain Nerve Shinkei Kenky? No Shinpo, vol.65, pp.413-436, 2013. ,
Enteritis, The Journal of Infectious Diseases, vol.193, issue.4, pp.547-55, 2006. ,
DOI : 10.1086/499969
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barr?? syndrome, Journal of Clinical Investigation, vol.114, issue.11, pp.1659-65, 2004. ,
DOI : 10.1172/JCI15707DS1
A Campylobacter jejuni gene associated with immune-mediated neuropathy, Nature Medicine, vol.275, issue.7, pp.752-755, 2001. ,
DOI : 10.1074/jbc.275.6.3896
Origin of ganglioside complex antibodies in Guillain???Barr?? syndrome, Journal of Neuroimmunology, vol.188, issue.1-2, pp.69-73, 2007. ,
DOI : 10.1016/j.jneuroim.2007.05.014
Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies, Neurology, vol.67, issue.10, pp.1837-1880, 2006. ,
DOI : 10.1212/01.wnl.0000244468.22377.6b
Antecedent infections in Fisher syndrome: A common pathogenesis of molecular mimicry, Neurology, vol.64, issue.9, pp.1605-1616, 2005. ,
DOI : 10.1212/01.WNL.0000160399.08456.7C
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome, Proceedings of the National Academy of Sciences, vol.52, issue.9, pp.11404-11413, 2004. ,
DOI : 10.1212/WNL.52.9.1833
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain???Barr?? syndrome, Journal of Neuroimmunology, vol.194, issue.1-2, pp.181-90, 2008. ,
DOI : 10.1016/j.jneuroim.2007.11.017
Infectious origins of, and molecular mimicry in, Guillain-Barr?? and Fisher syndromes, The Lancet Infectious Diseases, vol.1, issue.1, pp.29-37, 2001. ,
DOI : 10.1016/S1473-3099(01)00019-6
Intraneural activated T cells cause focal breakdown of the blood-nerve barrier, Brain, vol.118, issue.4, pp.857-68, 1995. ,
DOI : 10.1093/brain/118.4.857
Peripheral nervous system demyelination from systemic transfer of experimental allergic neuritis serum, Journal of Neuroimmunology, vol.41, issue.2, pp.159-66, 1992. ,
DOI : 10.1016/0165-5728(92)90066-T
T cell responses to myelin proteins in Guillain-Barr?? syndrome, Journal of the Neurological Sciences, vol.111, issue.2, pp.200-203, 1992. ,
DOI : 10.1016/0022-510X(92)90069-W
Molecular mimicry and the autoimmune response to the peripheral nerve myelin PO glycoprotein, Neurochemical Research, vol.23, issue.Suppl, pp.887-91, 1992. ,
DOI : 10.1007/BF00993264
Expanding and converting regulatory T cells: a horizon for immunotherapy, Archivum Immunologiae et Therapiae Experimentalis, vol.178, issue.3, 2009. ,
DOI : 10.4049/jimmunol.178.4.2018
The role of chemokines in guillain-barr?? syndrome, Muscle & Nerve, vol.8, issue.suppl, pp.320-350, 2013. ,
DOI : 10.1038/nrd2734
Immunotherapy for Guillain-Barre syndrome: a systematic review, Brain, vol.130, issue.9, pp.2245-57, 2007. ,
DOI : 10.1093/brain/awm004
Rational therapy of Guillain-Barré syndrome. The Lancet, p.753, 1998. ,
Plasma exchange (plasmapheresis) Agents Actions Suppl, pp.62-67, 1980. ,
Plasmapheresis in autoimmune syndromes, Indications. Results. Nouv Presse Médicale, vol.11, pp.3847-51, 1982. ,
Neurologic indications for therapeutic plasma exchange: 2013 update, Journal of Clinical Apheresis, vol.77, issue.2, 2014. ,
DOI : 10.1212/WNL.0b013e31822e55e7
The number of plasma exchanges in Guillain-Barré syndrome: evaluation by the removal rate of immunoglobulin G, Rinsh? Shinkeigaku Clin Neurol, vol.38, pp.951-955, 1998. ,
Modern Plasma Fractionation, Transfusion Medicine Reviews, vol.21, issue.2, pp.101-118, 2007. ,
DOI : 10.1016/j.tmrv.2006.11.001
Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance, Vox Sanguinis, vol.12, issue.Suppl 15, pp.12-28, 2010. ,
DOI : 10.1212/WNL.44.2.223
Intravenous Immunoglobulins Modulate Neutrophil Activation and Vascular Injury Through Fc??RIII and SHP-1, Circulation Research, vol.110, issue.8, pp.1057-66, 2012. ,
DOI : 10.1161/CIRCRESAHA.112.266411
Modulation of mononuclear phagocyte function by intravenous gamma-globulin, J Immunol Baltim Md, vol.132, pp.745-50, 1950. ,
Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb, J Immunol Baltim Md, vol.173, pp.332-341, 1950. ,
Gene Expression Profiling of the Effect of High-Dose Intravenous Ig in Patients with Kawasaki Disease, The Journal of Immunology, vol.174, issue.9, pp.5837-5882, 1950. ,
DOI : 10.4049/jimmunol.174.9.5837
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?, Nature Reviews Immunology, vol.113, issue.3, pp.176-89, 2013. ,
DOI : 10.1182/blood-2008-07-166439
IgG1 and IVIg induce inhibitory ITAM signaling through Fc??RIII controlling inflammatory responses, Blood, vol.119, issue.13, pp.3084-96, 2012. ,
DOI : 10.1182/blood-2011-08-376046
URL : http://www.bloodjournal.org/content/bloodjournal/119/13/3084.full.pdf
Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor, Science, vol.291, issue.5503, pp.484-490, 2001. ,
DOI : 10.1126/science.291.5503.484
Identification of a receptor required for the anti-inflammatory activity of IVIG, Proceedings of the National Academy of Sciences, vol.8, issue.6, 2008. ,
DOI : 10.1038/ni1470
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions, Journal of Clinical Investigation, vol.115, issue.10, pp.2914-2937, 2005. ,
DOI : 10.1172/JCI24772
FcRn: the neonatal Fc receptor comes of age, Nature Reviews Immunology, vol.100, issue.9, pp.715-740, 2007. ,
DOI : 10.4049/jimmunol.178.8.5390
Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR, The Journal of Immunology, vol.184, issue.4, 1950. ,
DOI : 10.4049/jimmunol.0903296
FcRn, un r??cepteur d???IgG aux multiples facettes, m??decine/sciences, vol.25, issue.12, pp.1053-1059, 2009. ,
DOI : 10.1051/medsci/200925121053
URL : http://www.medecinesciences.org/articles/medsci/pdf/2009/12/medsci20092512p1053.pdf
Pooled human immunoglobulins contain anti-idiotypes with reactivity against the SLE-associated 4B4 crossreactive idiotype, Clin Exp Rheumatol, vol.14, pp.587-91, 1996. ,
Normal human plasma contains antibodies that specifically block neuropathy-associated human anti-GM1 IgG-antibodies, Journal of Neuroimmunology, vol.105, issue.2, pp.179-83, 2000. ,
DOI : 10.1016/S0165-5728(99)00276-3
Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus, International Immunology, vol.14, issue.11, pp.1303-1314, 2002. ,
DOI : 10.1093/intimm/dxf099
Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function, The Journal of Immunology, vol.179, issue.8, pp.5571-5576, 1950. ,
DOI : 10.4049/jimmunol.179.8.5571
Intravenous Immunoglobulin Attenuates Experimental Autoimmune Arthritis by Inducing Reciprocal Regulation of Th17 and Treg Cells in an Interleukin-10-Dependent Manner, Arthritis & Rheumatology, vol.38, issue.Suppl 1, pp.1768-78, 2014. ,
DOI : 10.1002/eji.200838331
Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells, Clinical & Experimental Immunology, vol.112, issue.1 Suppl. 57, pp.259-67, 2013. ,
DOI : 10.1182/blood-2008-02-138073
Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis, Blood, vol.111, issue.2, pp.715-737, 2008. ,
DOI : 10.1182/blood-2007-03-079947
Anti-Inflammatory Effect of Intravenous Immunoglobulin Mediated Through Modulation of Complement Activation, Clinical Reviews in Allergy & Immunology, vol.29, issue.3, pp.207-219, 2005. ,
DOI : 10.1385/CRIAI:29:3:207
Intravenous immunoglobulin (IVIG)-mediated neutralisation of C5a: a direct mechanism of IVIG in the maintenance of a high FcgammaRIIB to FcgammaRIII expression ratio on macrophages, British Journal of Haematology, vol.174, issue.3, pp.345-352, 2006. ,
DOI : 10.4049/jimmunol.174.5.3041
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain-Barr?? Syndrome, New England Journal of Medicine, vol.326, issue.17, pp.1123-1132, 1992. ,
DOI : 10.1056/NEJM199204233261705
Guillain-Barré disease: a current treatment method using immunoglobulins, Ned Tijdschr Geneeskd, vol.136, 1992. ,
Intravenously Administered Immunoglobulin in the Treatment of Childhood Guillain-Barre Syndrome: A Randomized Trial, PEDIATRICS, vol.116, issue.1, pp.8-14, 2005. ,
DOI : 10.1542/peds.2004-1324
Safety of intravenous immunoglobulin (IVIG) therapy, Autoimmunity Reviews, vol.6, issue.4, pp.257-266, 2007. ,
DOI : 10.1016/j.autrev.2006.08.011
Indications and safety aspects of vacuum-assisted wound closure, MMW Fortschr Med, vol.147, pp.1-5, 2005. ,
Intravenous immunoglobulins and acute renal failure: mechanism and prevention. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.4-6, 2007. ,
Acute Renal Failure and Intravenous Immune Globulin: Occurs with Sucrose-Stabilized, but Not with D-Sorbitol???Stabilized, Formulation, Annals of Pharmacotherapy, vol.19, issue.1, pp.2059-67, 2004. ,
DOI : 10.1159/000179925
Acute Renal Failure, Translocational Hyponatremia and Hyperkalemia following Intravenous Immunoglobulin Therapy, Nephron Clinical Practice, vol.106, issue.4, pp.143-151, 2007. ,
DOI : 10.1001/archinte.1942.00200160121010
Increased risk of adverse events when changing intravenous immunoglobulin preparations, Clinical & Experimental Immunology, vol.74, issue.Suppl. 15, pp.111-114, 2004. ,
DOI : 10.1067/mai.2002.129359
Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature, British Journal of Dermatology, vol.46, issue.4, pp.714-735, 2006. ,
DOI : 10.1212/WNL.46.1.250
Adverse Effects of IgG Therapy, The Journal of Allergy and Clinical Immunology: In Practice, vol.1, issue.6, pp.558-66, 2013. ,
DOI : 10.1016/j.jaip.2013.09.012
Adverse Effects of Human Immunoglobulin Therapy, Transfusion Medicine Reviews, vol.27, issue.3, pp.171-179, 2013. ,
DOI : 10.1016/j.tmrv.2013.05.004
European consensus proposal for immunoglobulin therapies, European Journal of Immunology, vol.23, issue.Suppl. 1, 2014. ,
DOI : 10.1097/BOR.0b013e3283412fd4
Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome, The Lancet [Internet]. mars, vol.341, 1993. ,
Corticosteroids for Guillain-Barré syndrome, Cochrane Database Syst Rev, vol.8, 2012. ,
Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr?? syndrome: randomised trial, The Lancet, vol.363, issue.9404, pp.192-198, 2004. ,
DOI : 10.1016/S0140-6736(03)15324-X
Sodium channel inactivation in an animal model of acute quadriplegic myopathy, Annals of Neurology, vol.78, issue.1, pp.26-33, 2001. ,
DOI : 10.1016/S0306-4522(96)00624-0
Loss of electrical excitability in an animal model of acute quadriplegic myopathy, Annals of Neurology, vol.14, issue.2, pp.171-180, 1998. ,
DOI : 10.1001/archneur.1972.00490080099012
Treatment of Guillain Barre syndrome with mycophenolate mofetil: a pilot study, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.9, pp.1012-1015, 2007. ,
DOI : 10.1136/jnnp.2006.102731
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model, Brain, vol.1, issue.5, pp.1197-208, 2008. ,
DOI : 10.1016/S1473-3099(01)00019-6
Intravenous immunoglobulin for Guillain-Barré syndrome, Cochrane Database Syst Rev, vol.7, 2012. ,
Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barr?? syndrome, BMC Health Services Research, vol.71, issue.Suppl 4, p.101, 2011. ,
DOI : 10.1212/01.wnl.0000316393.54258.d1
Intravenous immunoglobulin for Guillain- Barré syndrome, Cochrane Database Syst Rev, issue.2, 2001. ,
DOI : 10.1002/14651858.cd002063.pub5
URL : http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD002063.pub5/pdf/abstract
Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement. Ther Apher Dial Off Peer-Rev J, pp.409-421, 2004. ,
Intravenous immunoglobulin therapy for Miller Fisher syndrome, Neurology, vol.68, issue.14, pp.1144-1150, 2007. ,
DOI : 10.1212/01.wnl.0000258673.31824.61
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome, Cochrane Database Syst Rev, vol.2, 2013. ,
Plasma Exchange After Initial Intravenous Immunoglobulin Treatment in Guillain-Barr?? Syndrome: Critical Reassessment of Effectiveness and Cost-Efficiency, Journal of Clinical Neuromuscular Disease, vol.12, issue.2, pp.55-61, 2010. ,
DOI : 10.1097/CND.0b013e3181f3dbbf
Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barr?? syndrome, The Lancet, vol.350, issue.9093, p.1747, 1997. ,
DOI : 10.1016/S0140-6736(97)24050-X
Intravenous immunoglobulin for Guillain-Barré syndrome, Cochrane Database Syst Rev, vol.9, 2014. ,
Treatment related fluctuations in Guillain-Barre syndrome after high-dose immunoglobulins or plasma-exchange., Journal of Neurology, Neurosurgery & Psychiatry, vol.54, issue.11, pp.957-60, 1991. ,
DOI : 10.1136/jnnp.54.11.957
Subacute Idiopathic Demyelinating Polyradiculoneuropathy, Archives of Neurology, vol.49, issue.6, pp.612-618, 1992. ,
DOI : 10.1001/archneur.1992.00530300044009
Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: A prospective study, Neurology, vol.74, issue.21, pp.1680-1686, 2010. ,
DOI : 10.1212/WNL.0b013e3181e07d14
Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barr??? syndrome, Journal of Neurology, vol.250, issue.8, pp.913-919, 2003. ,
DOI : 10.1007/s00415-003-1096-y
Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barr???? syndrome, Annals of Neurology, vol.35, issue.5, pp.597-603, 2009. ,
DOI : 10.1212/WNL.35.8.1096
Supportive Care for Patients With Guillain-Barr?? Syndrome, Archives of Neurology, vol.62, issue.8, pp.1194-1202, 2005. ,
DOI : 10.1001/archneur.62.8.1194
Detection of serious bradyarrhythmias in Guillain-Barr?? syndrome: Sensitivity and specificity of the 24-hour heart rate power spectrum, Clinical Autonomic Research, vol.97, issue.4, pp.185-91, 2000. ,
DOI : 10.1161/01.CIR.97.20.2031
Acute Autonomic, Sensory and Motor Neuropathy: Successful Treatment with IVIg, Internal Medicine, vol.48, issue.10, pp.843-849, 2009. ,
DOI : 10.2169/internalmedicine.48.1848
Epidural fentanyl-bupivacaine infusion for management of pain in the Guillain-Barré syndrome, Reg Anesth, vol.17, pp.171-175, 1992. ,
Epidural Opioids for the Management of Pain in a Patient with the Guillain-Barr?? Syndrome, Anesthesiology, vol.72, issue.2, pp.381-384, 1990. ,
DOI : 10.1097/00000542-199002000-00026
Epidural Morphine Treatment of Pain in Guillain-Barre Syndrome, Archives of Neurology, vol.43, issue.11, pp.1194-1200, 1986. ,
DOI : 10.1001/archneur.1986.00520110080023
The Comparative Evaluation of Gabapentin and Carbamazepine for Pain Management in Guillain-Barr?? Syndrome Patients in the Intensive Care Unit, Anesthesia & Analgesia, vol.101, issue.1, pp.220-225, 2005. ,
DOI : 10.1213/01.ANE.0000152186.89020.36
Carbamezapine for pain management in Guillain-Barr?? syndrome patients in the intensive care unit, Critical Care Medicine, vol.28, issue.3, pp.655-663, 2000. ,
DOI : 10.1097/00003246-200003000-00009
Gabapentin for the Treatment of Pain in Guillain-Barr?? Syndrome: A Double-Blinded, Placebo-Controlled, Crossover Study, Anesthesia & Analgesia, vol.95, issue.6, pp.1719-1742, 2002. ,
DOI : 10.1097/00000539-200212000-00046
Inter??t de la corticoth??rapie dans le traitement de la douleur ?? la phase aigu?? du syndrome de Guillain-Barr??, Revue Neurologique, vol.160, issue.8-9, pp.821-824, 2004. ,
DOI : 10.1016/S0035-3787(04)71037-1
Rehabilitation in Guillian Barre syndrome, Aust Fam Physician, vol.33, pp.1013-1020, 2004. ,
Multidisciplinary care for Guillain-Barré syndrome. Cochrane Database Syst Rev, 2010. ,
Rehabilitation interventions in patients with acute demyelinating inflammatory polyneuropathy: a systematic review, Eur J Phys Rehabil Med, vol.48, pp.507-529, 2012. ,
Residual fatigue is independent of antecedent events and disease severity in Guillain-Barr?? syndrome, Journal of Neurology, vol.54, issue.8, pp.1143-1149, 2006. ,
DOI : 10.1212/WNL.54.3.620
Fatigue in immune-mediated neuropathies, Neuromuscular Disorders, vol.22, pp.203-210, 2012. ,
DOI : 10.1016/j.nmd.2012.10.014
Disability and health-related quality of life in Guillain-Barr?? syndrome during the first two years after onset: a prospective study, Clinical Rehabilitation, vol.17, issue.8, pp.900-909, 2005. ,
DOI : 10.1212/WNL.59.1.84
Health-related quality of life in Guillain-Barr?? syndrome patients: a systematic review, Journal of the Peripheral Nervous System, vol.366, issue.1, pp.24-35, 2014. ,
DOI : 10.1056/NEJMra1114525
Nerve conduction studies in relation to residual fatigue in Guillain-Barr?? syndrome, Journal of Neurology, vol.45, issue.7, pp.851-857, 2006. ,
DOI : 10.1212/WNL.18.12.1143
Conduction velocity distribution in neurologically well-recovered but fatigued Guillain???Barr?? syndrome patients, Muscle & Nerve, vol.187, issue.2, pp.177-82, 2006. ,
DOI : 10.1212/WNL.53.8.1648
Contribution of central and peripheral factors to residual fatigue in Guillain???Barr?? syndrome, Muscle & Nerve, vol.95, issue.1, pp.93-102, 2007. ,
DOI : 10.1212/01.WNL.0000081049.14098.50
A prospective study of physiotherapist prescribed community based exercise in inflammatory peripheral neuropathy, Journal of Neurology, vol.87, issue.2, pp.228-263, 2007. ,
DOI : 10.1136/bmj.314.7094.1580
Analysing the favourable effects of physical exercise: relationships between physical fitness, fatigue and functioning in Guillain-Barr?? syndrome and chronic inflammatory demyelinating polyneuropathy, Journal of Rehabilitation Medicine, vol.39, issue.2, pp.121-126, 2007. ,
DOI : 10.2340/16501977-0007
Physical training and fatigue, fitness, and quality of life in Guillain-Barre syndrome and CIDP, Neurology, vol.63, issue.12, pp.2393-2398, 2004. ,
DOI : 10.1212/01.WNL.0000148589.87107.9C
Outcomes of high- and low-intensity rehabilitation programme for persons in chronic phase after Guillain-Barr?? syndrome: A randomized controlled trial, Journal of Rehabilitation Medicine, vol.43, issue.7, pp.638-684, 2011. ,
DOI : 10.2340/16501977-0826
A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain-Barr?? syndrome, Critical Care, vol.15, issue.1, p.65, 2011. ,
DOI : 10.1097/01.CCM.0000186898.58709.AA
L'insuffisance respiratoire aigu?? du syndrome de Guillain-Barr?? et de la myasth??nie auto-immune. De la d??tection au sevrage de la ventilation m??canique, R??animation, vol.14, issue.2, pp.118-143, 2005. ,
DOI : 10.1016/j.reaurg.2004.10.016
Prediction of respiratory insufficiency in Guillain-Barr?? syndrome, Annals of Neurology, vol.67, pp.781-788, 2010. ,
DOI : 10.1002/ana.21976
Repeated Vital Capacity Measurements as Predictive Parameters for Mechanical Ventilation Need and Weaning Success in the Guillain-Barr?? Syndrome, American Review of Respiratory Disease, vol.142, issue.4, pp.814-822, 1991. ,
DOI : 10.1056/NEJM198603203141209
Anticipating Mechanical Ventilation in Guillain-Barr?? Syndrome, Archives of Neurology, vol.58, issue.6, pp.893-901, 2001. ,
DOI : 10.1001/archneur.58.6.893
Tracheostomy in Guillain-Barr??? syndrome, Muscle & Nerve, vol.60, issue.8, pp.1058-62, 1999. ,
DOI : 10.1212/WNL.35.8.1096
Aerosolized Lidocaine During Invasive Mechanical Ventilation, Journal of Neurosurgical Anesthesiology, vol.25, issue.1, pp.8-15, 2013. ,
DOI : 10.1097/ANA.0b013e31826a75b1
Respiratory failure in Guillain-Barré syndrome: a 6-year experience, Mayo Clin Proc, vol.57, pp.742-748, 1982. ,
Guillain-Barre syndrome: Management of respiratory failure, Neurology, vol.35, issue.11, pp.1662-1667, 1985. ,
DOI : 10.1212/WNL.35.11.1662
Propofol and bradycardia: causation, frequency and severity, British Journal of Anaesthesia, vol.78, issue.6, pp.642-51, 1997. ,
DOI : 10.1093/bja/78.6.642
Guillain-Barre syndrome and SIADH, Neurology, vol.76, issue.8, pp.701-705, 2011. ,
DOI : 10.1212/WNL.0b013e31820d8b40
Early vs Late Tracheotomy for Prevention of Pneumonia in Mechanically Ventilated Adult ICU Patients, JAMA, vol.303, issue.15, pp.1483-1492, 2010. ,
DOI : 10.1001/jama.2010.447
Early Percutaneous Tracheotomy Versus Prolonged Intubation of Mechanically Ventilated Patients After Cardiac Surgery, Annals of Internal Medicine, vol.154, issue.6, pp.373-83, 2011. ,
DOI : 10.7326/0003-4819-154-6-201103150-00002
The Timing of Tracheotomy in Critically Ill Patients Undergoing Mechanical Ventilation, Chest, vol.140, issue.6, pp.1456-65, 2011. ,
DOI : 10.1378/chest.11-2024
Mechanical Ventilation in Guillain-Barr?? Syndrome: Does Age Influence Functional Outcome?, European Neurology, vol.61, issue.6, pp.358-63, 2009. ,
DOI : 10.1159/000210548
Prevalence, Risk Factors, and Mortality for Ventilator-Associated Pneumonia in Middle-Aged, Old, and Very Old Critically Ill Patients*, Critical Care Medicine, vol.42, issue.3, pp.601-610, 2014. ,
DOI : 10.1097/01.ccm.0000435665.07446.50